Pre-surgical statin-treatment in a window-of-opportunity breast cancer trial: Changes in gene expression profiles

被引：0
|
作者：
Bjarnadottir, Olof [1 ]
Johansson, Ida [1 ]
Veerla, Srinivas [2 ]
Jirstrom, Karin [3 ]
Grabau, Dorthe [3 ]
Hedenfalk, Ingrid [1 ]
Borgquist, Signe [1 ]
机构：
[1] Lund Univ, Div Oncol, Dept Clin Sci, Lund, Sweden
[2] Lund Univ, SCIBLU Genom, Lund, Sweden
[3] Lund Univ, Div Pathol, Lund, Sweden
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-CT308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT308
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pre-surgical Trial of Metformin in Overweight and Obese, Multiethnic Patients with Newly Diagnosed Breast Cancer
    Kalinsky, K.
    Crew, K. D.
    Refice, S.
    Wang, A.
    Feldman, S. M.
    Taback, B.
    Hibshoosh, H.
    Maurer, M.
    Hershman, D. L.
    [J]. CANCER RESEARCH, 2012, 72
  • [22] Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
    Lori J. Goldstein
    Raymond P. Perez
    Denise Yardley
    Linda K. Han
    James M. Reuben
    Hui Gao
    Susan McCanna
    Beth Butler
    Pier Adelchi Ruffini
    Yi Liu
    Roberto R. Rosato
    Jenny C. Chang
    [J]. Breast Cancer Research, 22
  • [23] Phase II pre-surgical window trial of telapristone acetate (TPA) in early breast cancer and DCIS patients: Distribution of TPA in plasma, normal breast tissue and tumors
    Lee, O.
    Muzzio, M.
    Ivancic, D.
    Rogers, C.
    Allu, S.
    Khan, S. A.
    [J]. CANCER RESEARCH, 2017, 77
  • [24] Racial Differences in Estrogen Receptor Signaling Pathway Activity in Breast Cancer Patients Selected for Short-course Pre-operative Hormone Therapy: A Window-of-Opportunity Trial
    Done, Joy
    Naik, Nivali
    Soleimani, Tahereh
    Keizer, Diederick
    Klein, Catherine
    Habibi, Mehran
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S415 - S416
  • [25] The medical geneticists role in the multidisciplinary breast cancer pre-surgical treatment planning conference.
    Young, SR
    Brooks, KA
    Kaneko, S
    Butler, WM
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 374 - 374
  • [26] Impact of RANKL inhibition on tumor microenvironment of early-stage breast cancer, a pre-surgical trial
    Marks, Douglas Kanter
    Axelrod, Deborah
    Kwa, Maryann
    Tray, Nancy
    Hiotis, Karen
    Guth, Amber
    Novik, Yelena
    Speyer, James
    Ty, Victor
    Heguy, Adriana
    Goldberg, Judith
    Darvishian, Farbod
    Adams, Sylvia
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [27] Window-of Opportunity Study of Valproic Acid in Breast Cancer Testing a Gene Expression Biomarker
    Cohen, Adam L.
    Neumayer, Leigh
    Boucher, Ken
    Factor, Rachel E.
    Shrestha, Gajendra
    Wade, Mark
    Lamb, John G.
    Arbogast, Kylee
    Piccolo, Stephen R.
    Riegert, Joanna
    Schabel, Matthias
    Bild, Andrea H.
    Werner, Theresa L.
    [J]. JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 11
  • [28] CHANGES IN T CELL CLONALITY IN AWARE-1 STUDY, A WINDOW-OF-OPPORTUNITY STUDY WITH ATEZOLIZUMAB AND THE ONCOLYTIC VIRUS PELAREOREP IN EARLY BREAST CANCER
    Manso, Luis
    Villagrasa, Patricia
    Chic, Nuria
    Bermejo, Begona
    Cejalvo, Juan
    Izarzugaza, Yann
    Cantos, Blanca
    Blanch, Salvador
    Margeli, Mireia
    Alonso, Jose
    Martinez, Alejandro
    Villanueva, Rafael
    Guerra, Juan
    Andres, Raquel
    Zamora, Pilar
    Nogales, Esteban
    Juan, Manel
    Gonzalez-Farre, Blanca
    Heineman, Thomas
    Nuovo, Gerard
    Wilkinson, Grey
    Coffey, Matt
    Gonzalez, Azucena
    Martinez, Debora
    Pare, Laia
    Salvador, Fernando
    Gonzalez, Xavier
    Prat, Aleix
    Gavila, Joaquin
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A482 - A482
  • [29] SOLTI-1805 TOT-HER3 trial: A window-of-opportunity trial of patritumab deruxtecan (HER3-DXd) in patients with treatment-naive, early breast cancer
    Oliveira, M.
    Cejalvo Andujar, J. M.
    Margeli Vila, M.
    Tolosa Ortega, P.
    Martinez Saez, O.
    Salvador Bofill, F. J.
    Cruz Jurado, J.
    Barrera, A. M. Luna
    Arumi De Dios, M. A.
    Vidal Losada, M. J.
    Guerra, J. A.
    Pernas Simon, S.
    Villacampa Javierre, G.
    Gonzalez-Farre, B.
    Sanfeliu Torres, E.
    Santhanagopal, A.
    Falato, C.
    Ferrero Cafiero, J. M.
    Pascual, T.
    Prat, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S628 - S628
  • [30] Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial
    K. Kalinsky
    J. A. Sparano
    X. Zhong
    E. Andreopoulou
    B. Taback
    L. Wiechmann
    S. M. Feldman
    P. Ananthakrishnan
    A. Ahmad
    S. Cremers
    A. N. Sireci
    J. R. Cross
    D. K. Marks
    P. Mundi
    E. Connolly
    K. D. Crew
    M. A. Maurer
    H. Hibshoosh
    S. Lee
    D. L. Hershman
    [J]. Clinical and Translational Oncology, 2018, 20 : 1474 - 1483
12345